Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial

Journal:

Nature Medicine

Published:

2025-09-04

DOI:

10.1038/s41591-025-03935-w

Affiliations:

7

Authors:

16

Go to article

Institutions	Authors	Share
Erasmus MC Cancer Institute, Netherlands	11.000000 11.000000	0.69
Amstelland Hospital, Netherlands	1.000000	0.06
Maasstad Hospital, Netherlands	1.000000	0.06
Frisius MC, Netherlands	1.000000	0.06
Netherlands Cancer Institute (NKI), Netherlands	1.000000	0.06
Cancer Center Amsterdam (CCA), Netherlands	0.500000	0.03
Amsterdam UMC, Netherlands	0.500000	0.03

Interested in Oncology and Carcinogenesis?